3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immunostimulant activity

Details for Australian Patent Application No. 2006209209 (hide)

Owner Allergan, Inc.

Inventors Beausoleil, Eric; Taverne, Thierry; Leblond, Bertrand; Donello, John E.

Agent Davies Collison Cave

Pub. Number AU-B-2006209209

PCT Pub. Number WO2006/081273

Priority 60/647,271 26.01.05 US

Filing date 25 January 2006

Wipo publication date 3 August 2006

Acceptance publication date 19 July 2012

International Classifications

C07D 213/81 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

A61K 31/381 - having five-membered rings

A61K 31/4409 - only substituted in position 4, e.g. isoniazid, iproniazid

A61P 29/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 37/04 Drugs for immunological or allergic disorders

C07D 213/61 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/64 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/73 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 215/14 Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 295/18 Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 307/54 Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 333/24 Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

C07D 333/38 Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

C07D 333/60 Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

C07D 401/06 Heterocyclic compounds containing two or more hetero rings

Event Publications

16 August 2007 PCT application entered the National Phase

  PCT publication WO2006/081273 Priority application(s): WO2006/081273

20 September 2007 Amendment Made

  The nature of the amendment is: Amend the invention title to read 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immunostimulant activity

19 July 2012 Application Accepted

  Published as AU-B-2006209209

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006209212-Controlled release compositions comprising an antipsychotic agent

2006209208-1-aryl-1-hydroxy-2,3-diamino-propyl amines, 1-heteroary1-1-hydroxy2,3-diamino-propyl amines and related compounds having analgesic and/ or immuno stimulant activity